eGNA Case Conference

eGNA Case Conference

Case Study Abstract Form

Instructions

Submit your individual/team case study abstract in the fields below.

Do not submit PHI (Protected Health Information) in your abstract.

You will be notified once the eGNA Advisory Board has reviewed your abstract and has decided to select / not select your case for full submission.


































Submit your individual/team case study abstract in the fields below.

Sections:

  • Title of Abstract
  • Body of Abstract
    • Description - Patient overview (no PHI or specific patient information), screening, diagnosis and treatment approach, and overview of clinical signs/symptoms.
    • Significance - Lessons learned, gaps
    • Conclusion and Next Steps - Queries, future directions

Body of Abstract is limited to 1500 characters.

No PHI in Abstract

LIMIT: 1500 characters


Design originally by SiGa, with customization by Adrya Stembridge © 2018